Muscle strength in elderly adults with GH deficiency after 10 years of GH replacement
- PMID: 20463152
- DOI: 10.1530/EJE-10-0009
Muscle strength in elderly adults with GH deficiency after 10 years of GH replacement
Abstract
Context: Only few studies have investigated the effects of GH replacement on muscle strength in elderly patients with GH deficiency (GHD). OBJECTIVE, DESIGN, AND PATIENTS: In this prospective open-labeled study, the effects of 10 years of GH replacement on muscle strength and neuromuscular function were followed in 24 elderly GHD adults (mean age of 65.2 years; range 61-74 years). Muscle strength was compared with reference values obtained from the background population.
Results: The mean initial GH dose of 0.72 mg/day was lowered to 0.37 mg/day. The mean IGF1 SDS increased from -1.10 at baseline to 1.17 at study end. GH replacement induced a sustained increase in lean body mass and a transient increase in isometric knee flexor strength. Isometric knee extensor strength was reduced after 10 years. However, after correction for age and gender, using observed/predicted value ratios, there was sustained and even progressive increase in most variables reflecting muscle strength. Measurements of neuromuscular function showed unchanged voluntary motor unit activation after 10 years.
Conclusions: Ten years of GH replacement therapy in elderly GHD adults resulted in a transient increase in isometric knee flexor strength, and provided protection from most of the normal age-related decline in muscle performance and neuromuscular function.
Similar articles
-
Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength.J Clin Endocrinol Metab. 2003 May;88(5):2061-9. doi: 10.1210/jc.2002-020901. J Clin Endocrinol Metab. 2003. PMID: 12727955
-
The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients.Clin Endocrinol (Oxf). 2005 Jan;62(1):105-13. doi: 10.1111/j.1365-2265.2004.02181.x. Clin Endocrinol (Oxf). 2005. PMID: 15638878 Clinical Trial.
-
Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults.J Clin Endocrinol Metab. 2009 Mar;94(3):809-16. doi: 10.1210/jc.2008-1538. Epub 2008 Dec 16. J Clin Endocrinol Metab. 2009. PMID: 19088164
-
The effect of growth hormone (GH) replacement on muscle strength in patients with GH-deficiency: a meta-analysis.Clin Endocrinol (Oxf). 2010 Jun;72(6):787-92. doi: 10.1111/j.1365-2265.2009.03716.x. Epub 2009 Sep 21. Clin Endocrinol (Oxf). 2010. PMID: 19769614 Review.
-
Impact of growth hormone status on body composition and the skeleton.Horm Res. 2004;62 Suppl 3:35-41. doi: 10.1159/000080497. Horm Res. 2004. PMID: 15539797 Review.
Cited by
-
Diagnosing and treating the elderly individual with hypopituitarism.Rev Endocr Metab Disord. 2024 Jun;25(3):575-597. doi: 10.1007/s11154-023-09870-w. Epub 2023 Dec 27. Rev Endocr Metab Disord. 2024. PMID: 38150092 Review.
-
Adult individuals with congenital, untreated, severe isolated growth hormone deficiency have satisfactory muscular function.Endocrine. 2019 Jan;63(1):112-119. doi: 10.1007/s12020-018-1763-5. Epub 2018 Sep 24. Endocrine. 2019. PMID: 30251164
-
Effects of Growth Hormone Administration on Muscle Strength in Men over 50 Years Old.Int J Endocrinol. 2013;2013:942030. doi: 10.1155/2013/942030. Epub 2013 Dec 8. Int J Endocrinol. 2013. PMID: 24382963 Free PMC article.
-
Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons.Curr Pharm Des. 2014;20(19):3119-48. doi: 10.2174/13816128113196660062. Curr Pharm Des. 2014. PMID: 24050169 Free PMC article. Review.
-
Ablation of leptin signaling to somatotropes: changes in metabolic factors that cause obesity.Endocrinology. 2012 Oct;153(10):4705-15. doi: 10.1210/en.2012-1331. Epub 2012 Aug 3. Endocrinology. 2012. PMID: 22865370 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous